- Disease: Respiratory syncytial virus infection
- Study type: Observational Cohort Study, Prevention
- Study type descriptors: Prospective, Single centre
- Objective: To evaluate vaccine immunogenicity in HSCT adult patients as a first estimation of its protective capacity in adults with such immune conditions
- Number of participants enrolled: 92
- Study enrolling from to
- Study includes follow-up for 12 weeks
Study Data
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Immunocompromised host
- Hospital
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Pharmacological intervention
- Vaccination
External Links
Other information
Funders/Sponsors:
- https://ror.org/00n95xs29
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to